Gut chemical defence and tissue recovery may extend life through two distinct functions
The proposal combines microbial gut defence with interchangeable muscle and epithelial recovery programmes. Failed reciprocal replacement of those programmes, or an independent lifespan benefit from either microbial component alone, would reject the proposed two-function minimum
Stage of verification
- Hypothesis published2026-10-05
- Not enough research data
- Direct testAwaited
Map of the hypothesis
Hover over an icon or tap it to see its name.
Where in the body
Biological function
The biological function description is being prepared
Kind of knowledge gap
A double ring marks the main placement where a group contains several values.
Target map
Every target of every published hypothesis, each with the actions a hypothesis can propose on it. The targets and the actions of this hypothesis are drawn solid.

Immune response
Microbial chemical defense
Chemical protection provided by microbes
Where this hypothesis actsIn the gut, acting on mature colonocytes and sensitive intestinal bacteria
Hypotheses on this target 1
Inhibition
Activation1
Function preservation
Clearance restoration
Immunosuppression
Feedback restoration
Rhythm restoration

What is proposed
Activation
Reproduce microbial chemical protection through combined B and L
With whatNot stated in the record
HowCombine B and L; the record does not identify these components. Neither component alone is proposed to provide an independent lifespan benefit
Possible result
Possible reduction in repeated intestinal damage and a distinct contribution to lifespan extension
From the recordПервый представляет собой составное воспроизведение микробной химической защиты кишечника B+L, действующее на зрелые колоноциты и чувствительные кишечные бактерии.

Rhythm or programme
Tissue repair
The process through which tissues recover from damage
Where this hypothesis actsTissues receiving a restorative pulse programme through muscle or epithelial inputs
Hypotheses on this target 1
Inhibition
Activation1
Function preservation
Feedback restoration
Rhythm restoration
Direct measurement

What is proposed
Activation
Trigger a sufficient tissue repair response through either C or E
With whatNot stated in the record
HowUse the interchangeable muscle implementation C or epithelial implementation E; combine them to maintain the response when one input temporarily fails
Possible result
Possible faster completion of tissue repair and more reliable preservation of its contribution to remaining lifespan
From the recordВторой воспроизводит восстановительную импульсную программу тканей и имеет две взаимозаменяемые реализации: мышечную C и эпителиальную E.
All targets of the lab
Every target read from the published hypotheses, each kind around its pictogram. A larger mark means more hypotheses act on that target. Point at a mark and the actions proposed on it branch out of it.
Solid and named: the targets of this hypothesis
Explore in depth
The logic
The train of thought that ends in this hypothesis. Each stage is the reason the next exists. The master question narrows to a goal, the goal to an unknown nobody has closed, the unknown to the hypothesis proposed here. Every step below says what it rests on and what carries it.
Protecting the gut and finishing tissue repairs might extend life through different functions. The unexpected move is to count muscle and tissue-lining recovery inputs as two ways of providing one function, while counting two gut chemicals together as another. This is a proposal generated by the pipeline, not a measured result.
- Two gut components together act on mature colon-lining cells and susceptible bacteria to provide the proposed chemical defence.
- Either the muscle input or the tissue-lining input activates the same proposed tissue-recovery response.
- When one recovery input temporarily stops producing that response, the other preserves it; two available inputs therefore provide backup for one function.
- Gut defence and tissue recovery supply different contributions, so a recovery input cannot replace the combined gut components.
- The two functions together are predicted to reduce repeated gut injury and hasten completion of repair in other tissues.
- Those changes are proposed to increase remaining life.
A building needs both a working lock and a working light. Two switches may operate the same light and provide backup for each other, but neither switch replaces the lock.
Where the picture breaks: Muscle and tissue-lining inputs have not been shown here to operate one identical recovery response. Their failures may also occur together, so having two inputs does not automatically provide independent backup.
- Master questionstep 01 of 04
Useful processes already performed by the body might be reproduced with substances, combinations or other interventions to extend life.
Rests on: The stated goal is to propose new mimetics, meaning interventions that reproduce useful effects of physiological processes, and explain why they might extend life.
Stated in the chain - Goal pillarstep 02 of 04
The intended output is a defined set of new interventions that reproduce bodily processes for life extension.
Rests on: The master question explicitly requests new candidates and explanations of their possible life-extending effects.
Stated in the chain - Gap questionstep 03 of 04
The number of genuinely separate candidates depends on which functions remain necessary when substances are exchanged, components removed and treatment phases reordered.
Rests on: Turning a collection of candidates into a defined set requires a way to distinguish interchangeable interventions from interventions supplying different necessary functions.
AssumptionThe stage assumes that relevant targets have already been established and that replacement, removal and phase-reordering comparisons can identify independent life-extending functions. The preceding stages do not establish those targets or that counting rule.
- Hypothesisstep 04 of 04
Two independent candidates are proposed: a combined chemical defence acting on mature colon-lining cells and susceptible gut bacteria, and a tissue-recovery program delivered in pulses through either muscle or tissue-lining cells. The recovery inputs are proposed to replace each other completely; the two gut components are proposed to require each other for a life-extension benefit.
Rests on: The preceding stage supplies the replacement-and-removal criterion used to formulate this proposed two-function arrangement. The endpoint also explicitly borrows a model of backup components to explain why retaining both recovery inputs might make one function more dependable.
Stated in the chain
What is carried, and what is not. The one screened source, S1, an eLife article from 2021, discusses timely removal of senescent cells—cells in a lasting state of growth arrest—and suggests that their persistence could impair regeneration; it does not establish the proposed gut components, interchangeable recovery inputs or life-extension effects. It supplies background for repair, but directly establishes none of this proposal's specific mechanism links or their sequence end to end.S1
Where the reasoning is carried by something unstated · 1
- Gap question. The stage assumes that relevant targets have already been established and that replacement, removal and phase-reordering comparisons can identify independent life-extending functions. The preceding stages do not establish those targets or that counting rule.
How a result here could mislead · 3
- Matching the fraction of animals retaining a useful response could be read as proof that the muscle and tissue-lining inputs perform the same function, even if they preserve different aspects of repair. What closes it: The required recovery profile must be specified before testing, and replacement must restore that profile and the corresponding contribution to remaining life in both directions. Equal response frequencies alone do not meet the proposal's criterion.
- An unsuccessful replacement could be read as evidence against interchangeability when the replacement input never produced its intended response, or when the procedure disabling the first input also impaired the second. What closes it: Loss of the original response and delivery of the replacement response must both be verified. Controls must distinguish loss of the targeted input from broader damage caused by the disabling procedure; the supplied material does not specify those controls.
- A higher fraction of animals retaining the recovery response could be mistaken for improved survival, and a calculation assuming independent failures could overstate the benefit of combining the inputs. What closes it: Response retention and survival must be measured separately. Failure of both inputs in the same animals must be measured, and the independent-failure calculation used only when its independence requirement holds.
What would make this wrong. The proposed two-function arrangement would be contradicted if, after verified loss of one recovery input and verified action of its replacement, replacement failed to restore the predefined recovery profile and corresponding contribution to remaining life in either direction. It would also be contradicted if either gut component alone supplied the claimed independent life-extension benefit, or if a recovery input fully replaced the combined gut defence. These are predictions of the proposal; the supplied material reports no such tests.
What it would change. If the predicted replacements and removals held, the search for life-extending mimetics would count two necessary functions in this candidate set, with muscle and tissue-lining interventions serving as alternative implementations of one of them. Candidate selection would therefore have to distinguish added functional coverage from backup for an existing function. Even successful results would not establish that two functions exhaust all routes to life extension, or that the effects transfer beyond the tested population, tissues and duration; those test boundaries are not specified in the supplied material.
Sources read · 1
The right time for senescence. · eLife · 2021
“Transversal to all these reports is the timely elimination of SCs, which suggests that their persistence could eventually turn detrimental for the regenerative response.”
Does not settle: The source does not establish the proposed gut microbial chemical defence, the B or L components, interchangeable muscle C and epithelial E recovery inputs, lifespan effects in the selected population, redundancy during temporary input insensitivity, distinct causal contributions, or benefits of combining the two mimetics.
The gap this hypothesis explains
Nothing is known here: the question has not been asked of this system.
How many functionally distinct life-extending treatments remain after swapping substances, removing components, or reordering treatment stages?
Original wording · exactly as the pipeline generated it
Сколько функционально самостоятельных миметиков продления жизни образуют воздействия на установленные мишени, если замена веществ, исключение компонентов и перестановка фаз позволяют отделить взаимозаменяемые воздействия от воспроизведения разных необходимых функций?
What this question is asking
The question concerns how many different useful bodily functions a set of life-extending treatments reproduces, rather than how many substances it contains. It asks whether replacing substances, removing parts of a treatment, or changing the order of treatment stages distinguishes interchangeable treatments from treatments that reproduce different necessary functions. The proposed count must remain consistent when equivalent substances are substituted across repeated treatment cycles and survival is followed for the rest of life. This assumes that the treatments act on established biological targets and that these comparisons can identify separate functions; the supplied sources do not establish those assumptions for a specified set of treatments.
- Mimetic
- A substance or other intervention intended to reproduce an effect of a bodily process. In this question, mimetics would be counted by the useful functions they reproduce, rather than simply by their ingredients.
- Functionally independent
- Providing a distinguishable useful contribution that cannot simply be replaced by another contribution in the treatment set. The supplied material does not establish a precise rule for deciding when that condition is met.
- Necessary function
- A contribution required for a specified benefit under specified conditions. A treatment improving survival does not, by itself, establish which of its effects was necessary.
- Biological target
- A part of biological machinery, such as a protein, on which a treatment acts. Identifying a target does not by itself establish a survival benefit or a distinct necessary function.
- Interchangeability
- The ability to replace one treatment component with another while preserving the relevant function and outcome. Here, that equivalence is required to persist across repeated treatment and remaining-life follow-up.
- Component removal
- Leaving an ingredient or other element out of a combined treatment. The question asks whether the resulting change can distinguish redundant contributions from necessary ones.
- Treatment stage or phase
- One scheduled part of a treatment sequence. Reordering phases changes when components act relative to one another, even if the components themselves remain the same.
- Treatment cycle
- One complete repetition of a treatment schedule. The requested count must remain meaningful after multiple repetitions.
- Lifespan and remaining-life follow-up
- Lifespan is the length of an organism's life. Remaining-life follow-up means observing survival from the relevant starting point until death, rather than relying only on an earlier measurement.
- Additive effect
- A combined effect described as adding the contributions of the treatments on the study's measurement scale. S2 uses this description, but the supplied quotation does not give the scale, effect sizes, or a demonstration of separate necessary functions.
- Trametinib
- One of the drugs studied in S2. The supplied quotation reports lifespan extension in male and female mice but does not describe its biological target.
- Rapamycin
- The second drug in the combination reported by S2. The supplied quotation describes the combination as additive but does not specify rapamycin's separate effect size or mechanism.
- Protein assembly
- A group of proteins working together within a cell. S8 reports that the assemblies it discusses have distinct cellular functions, without establishing that these correspond to distinct life-extending mimetics.
- Genetic change
- An alteration to an organism's inherited biological instructions. S1 mentions such changes as one way aging is studied, without reporting how they resolve the functional-count question.
The interventions act on established targets, and substance substitution, component removal, and phase reordering can distinguish interchangeable interventions from reproduction of different necessary functions.
The assumption concerns substances or other treatments acting on identified parts of the body's machinery. It assumes that exchanging ingredients, leaving ingredients out, and changing when they are given can reveal whether treatments do the same useful job or different necessary jobs. If that distinction holds through repeated use and lifelong follow-up, it would provide a basis for counting treatments by function.
The supplied sources do not identify the complete treatment set or establish this counting rule. S2 reports an additive survival benefit from combining two drugs, but the supplied account does not establish interchangeability, necessary functions, or stability under repeated substitutions and schedule changes. S8 describes protein assemblies with distinct cellular functions, which does not establish distinct life-extending treatments. No supplied source establishes the premise; this limitation does not show that the premise is false.S2S8
The same question asked without the part nothing read establishes:
- For a specified set of life-extending treatments, what evidence distinguishes interchangeable ingredients from ingredients contributing different functions?
- Do changes in treatment ingredients or their order preserve the survival benefit across repeated treatment cycles and the remaining lifespan?
- One shared function If the treatments reproduce the same useful function and substitutions preserve the survival benefit, different ingredients would represent alternative ways of supplying that function. Counting each ingredient or formulation as a separate functional treatment would overcount.
- Several distinct necessary functions If different treatment components provide different necessary functions, replacing one component with something that supplies another function would leave a contribution missing. A count based only on interchangeable ingredients would then fail to capture the separate functions required for the benefit.
- The count depends on timing or repeated use If an ingredient's contribution changes with treatment order or repeated cycles, equivalence under one schedule would not establish equivalence under another. The result would be a count tied to particular treatment conditions, rather than the stable count requested.
A treatment's ingredients, the biological processes it changes, and its effect on survival are different things. If two ingredients reproduce the same useful function, counting ingredients separately could overstate the number of distinct treatments. If different ingredients provide different necessary functions, treating them as interchangeable could remove a contribution needed for the survival benefit. If their order matters, changing the schedule could change the benefit even when the ingredients stay the same. The question therefore turns on whether differences in composition or timing correspond to differences in function that persist over the remaining lifespan.
S-узлы уровней RL-1 и RL-2 описывают заменяемые компоненты и зависимость от режима, но не устанавливают число самостоятельных миметиков.
Число самостоятельных миметиков устойчиво к замене эквивалентных компонентов на протяжении повторных циклов и наблюдения оставшейся жизни.
Неизвестно, сколько разных причинных функций реализует набор воздействий и когда изменение состава или последовательности создаёт самостоятельный миметик.
The mechanism it proposes
The engine's own statement of the hypothesis, in full.
Предлагаемый минимальный набор содержит два самостоятельных миметика. Первый представляет собой составное воспроизведение микробной химической защиты кишечника B+L, действующее на зрелые колоноциты и чувствительные кишечные бактерии. Второй воспроизводит восстановительную импульсную программу тканей и имеет две взаимозаменяемые реализации: мышечную C и эпителиальную E. Гипотеза утверждает, что C и E запускают один достаточный ответ хозяина, а совместное применение повышает вероятность его сохранения при временной нечувствительности одного входа. Компоненты B и L по отдельности дают ближайшие эффекты, но самостоятельного выигрыша жизни в выбранной популяции не обеспечивают. Микробный кандидат и кандидат тканевого восстановления дают разные причинные вклады; один представитель не покрывает обе функции. Их сочетание должно уменьшать повторное повреждение кишечника и ускорять завершение восстановления других тканей.
Where the idea comes from
The hypothesis borrows a result from another field. This is what it borrows, and from where.
Теория надёжности и резервирование, модель параллельных компонентов: R_H(t)=1-[1-R_C(t)][1-R_E(t)]. Здесь t обозначает число завершённых циклов; R_C(t) и R_E(t) обозначают вероятности сохранения заранее заданного полезного функционального ответа к циклу t при соответствующей реализации; R_H(t) обозначает вероятность сохранения того же ответа при наличии обеих реализаций. Каждую величину измеряют по доле животных с сохранённым ответом. Формула требует независимости отказов. При зависимости используют точное равенство R_H(t)=1-P(F_C(t)∩F_E(t)), где F_C и F_E обозначают измеренные события утраты ответа. Эти вероятности характеризуют работоспособность миметика, а не вероятность выживания животного. [Модель параллельного резервирования NIST](https://www.itl.nist.gov/div898/handbook/apr/section1/apr183.htm).
Testing and possible results
The prediction that would tell it apart
A hypothesis that predicts what its rivals predict is not worth running an experiment over. This is the observation on which this one differs.
После подтверждённого выпадения ответа на C воздействие E полностью восстанавливает заранее заданный профиль тканевого восстановления и соответствующий вклад в оставшуюся жизнь; обратная замена также успешна. Одновременное выпадение C и E устраняет этот вклад. Воздействия C или E не заменяют B+L. Исключение B либо L устраняет собственный выигрыш жизни микробного кандидата. Таким образом, две реализации C и E повышают надёжность одного миметика, сохраняя число самостоятельных кандидатов равным двум.
Would tell it apart from at least one rival. The prediction states measurable restoration, reciprocal substitution, non-substitution, and loss of specified contributions under stated conditions. No rival prediction is supplied. Only a bench experiment would settle it.
What testing it would take
The engine's own read on whether this is testable with methods that already exist.
Замены C и E доступны в клеточных и животных моделях. Наиболее трудная часть представляет собой проверку полной взаимозаменяемости по тканевым функциям и выживаемости. Совпадение вероятностей успеха само по себе функциональную эквивалентность не доказывает.
Other explanations
Every other hypothesis the engine wrote for the same gap, and the observation that would separate the two.
После подтверждённого выпадения ответа на C воздействие E полностью восстанавливает заранее заданный профиль тканевого восстановления и соответствующий вклад в оставшуюся жизнь; обратная замена также успешна. Одновременное выпадение C и E устраняет этот вклад. Воздействия C или E не заменяют B+L. Исключение B либо L устраняет собственный выигрыш жизни микробного кандидата. Таким образом, две реализации C и E повышают надёжность одного миметика, сохраняя число самостоятельных кандидатов равным двум.
- Rival 01 of 03What would separate them
One shared recovery pattern of kinase activity may extend life by completing tissue repair predicts: Избирательное нарушение восстановительной динамики ERK в названных клетках устраняет выигрыш жизни от каждого из четырёх воздействий при сохранении их ближайших эффектов, включая образование метаболитов и мышечные сокращения. Прямое воспроизведение траектории ERK восстанавливает тканевую функцию и выигрыш жизни после исключения любого из четырёх воздействий. Сохранение хотя бы одного самостоятельного выигрыша жизни при таком нарушении отвергает ответ «один» в пользу многокомпонентных ответов.
- What would separate them
Distinct signal decoders may separate muscle and epithelial longevity mimetics predicts: При сохранении суммарного воздействия изменение временного рисунка C избирательно устраняет мышечную адаптацию и её вклад в продолжительность жизни; E этот вклад не восстанавливает. Перестановка фаз E избирательно нарушает восстановление эпителия при сохранном ответе C. Возврат соответствующей последовательности восстанавливает только утраченную функцию. Одновременно B и L по отдельности сохраняют ближайшие эффекты, но выигрыш жизни даёт лишь их сочетание. Получается ровно три самостоятельных кандидата в ограниченном наборе.
- Rival 03 of 03What would separate them
Four distinct physiological mimetics may extend life through four independent functions predicts: B и L по отдельности увеличивают среднюю оставшуюся жизнь относительно контроля и сохраняют разные причинные зависимости. При замене чувствительных кишечных бактерий на функционально сопоставимые устойчивые варианты исчезает вклад L, тогда как вклад B сохраняется. При избирательном нарушении использования бутирата зрелыми колоноцитами исчезает вклад B, тогда как антимикробное действие и выигрыш от L сохраняются. Ни C, ни E не восстанавливают эти утраченные функции. Такая двойная диссоциация отвергает ответы с единым микробным кандидатом.
What stands behind it
Which of the figures above have a study behind them, which are the engine's own, and what it would take to refute the hypothesis. This audit never judges the idea.
This hypothesis states no figure and cites no study, so there is nothing here to trace.
What it would take to refute it. Nothing already retrieved carries the prediction’s terms and it names no measurement this layer can route to a public dataset, so the bench is the residual — not a finding against it.
0 citation handles extracted; 1 Europe PMC search run; 0 records examined; 0 sources stored for enrichment, 0 with full text. A citation that did not resolve is a bibliographic failure, not proof that no such paper exists, and no hypothesis is blocked by this audit.